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Abstract
Aging is associated with poor skeletal muscle regenerative ability following extended periods of hospitalization and
other forms of muscular disuse. Resveratrol (3,5,4’-trihydroxystilbene) is a natural phytoalexin which has been shown
in skeletal muscle to improve oxidative stress levels in muscles of aged rats. As muscle disuse and reloading after
disuse increases oxidative stress, we hypothesized that resveratrol supplementation would improve muscle
regeneration after disuse. A total of thirty-six male Fisher 344 × Brown Norway rats (32 mo.) were treated with either
a water vehicle or resveratrol via oral gavage. The animals received hindlimb suspension for 14 days. Thereafter,
they were either sacrificed or allowed an additional 14 day period of cage ambulation during reloading. A total of six
rats from the vehicle and the resveratrol treated groups were used for the hindlimb suspension and recovery
protocols. Furthermore, two groups of 6 vehicle treated animals maintained normal ambulation throughout the
experiment, and were used as control animals for the hindlimb suspension and reloading groups. The data show that
resveratrol supplementation was unable to attenuate the decreases in plantaris muscle wet weight during hindlimb
suspension but it improved muscle mass during reloading after hindlimb suspension. Although resveratrol did not
prevent fiber atrophy during the period of disuse, it increased the fiber cross sectional area of type IIA and IIB fibers
in response to reloading after hindlimb suspension. There was a modest enhancement of myogenic precursor cell
proliferation in resveratrol-treated muscles after reloading, but this failed to reach statistical significance. The
resveratrol-associated improvement in type II fiber size and muscle mass recovery after disuse may have been due
to decreases in the abundance of pro-apoptotic proteins Bax, cleaved caspase 3 and cleaved caspase 9 in reloaded
muscles. Resveratrol appears to have modest therapeutic benefits for improving muscle mass after disuse in aging.
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Introduction
Skeletal muscle comprises 40-50% of the total mass in an
average young adult human and is crucial for locomotion,
metabolism, generating heat, and the maintenance of posture
[1,2]. However, aging induces an inevitable loss in muscle
mass and function, due to a multitude of factors that together is
referred to as sarcopenia [3–5]. It is thought that as much as
50% of the population over the age of 80 suffers from
sarcopenia [6]. Sarcopenia has been shown to be predictive of
falls [7], possibly leading to extended hospital stays and
periods of immobilization. This is noteworthy, as aging muscles
display an impaired or failed recovery following immobilization-
induced muscle atrophy [8–10] .
Several potential treatments have been investigated as
potential countermeasure for unloading-induced atrophy, but
most have only been partially successful. For example, taurine
has been shown to prevent the typical slow to fast myosin shift
with unloading [11] but it does not prevent muscle loss. Insulin
growth factor-I overexpression during hindlimb unloading
induced some potential molecular signaling improvements,
especially the atrogen MurF1, but there was no overall
reduction in muscle protein loss or slow to fast fiber transition
loss with this treatment [12]. In addition, β-Hydroxy-β-
methylbutyrate (HMB) a leucine metabolite, also provides a
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e83518
modest protection against skeletal muscle loss during hindlimb
unloading in old rats [13], but again it does not prevent muscle
wasting. Resveratrol (3,5,4’-trihydroxystilbene) has been
shown to inhibit protein degradation and attenuate atrophy of
skeletal muscle fibers in several in vitro studies [14–17]. A
relatively high dose (400 mg/kg/day) of resveratrol, in vivo has
been shown to attenuate slow muscle fiber atrophy following
hindlimb suspension [18] in rodents. In agreement with these
data, we have found that a low dose (12.5 mg/kg/day) of
resveratrol [19] had a trend (p=0.06) to blunt fast muscle losses
during hindlimb suspension induced muscle wasting. However,
we do not know if resveratrol has the potential to improve
recovery of muscle after wasting conditions in aging. As muscle
regeneration and repair is critically dependent upon adequate
proliferation and differentiation of muscle stem cells (satellite
cells), it is important to know if resveratrol treatment would
improve satellite cell function or prevent nuclear loss (e.g.,
apoptosis) in vivo. This seems plausible because resveratrol
has been shown to improve non-cancer cell viability, reduce
apoptosis [20,21] and promote stem cell proliferation and cell
repair [22,23], but this is cell type and dose dependent.
Nevertheless, the function of resveratrol on skeletal muscle
stem cell function during muscle repair is less clear. Sirtuin 1, a
presumed target of resveratrol has been reported to increase
proliferation [24] of skeletal muscle stem cells/myoblasts in
culture, whereas resveratrol treatment has been found to
increase differentiation of myoblasts rather than proliferation in
vitro [23]. As resveratrol may function differently on skeletal
muscle satellite cells in vivo in aging vs. these in vitro studies,
we tested the hypothesis that resveratrol supplementation
would alter satellite cell proliferation and reduce pro-apoptotic
signaling to improve muscle regeneration in muscles of aged
rats following muscle disuse. This line of inquiry is important
because muscles from aged animals recover very little after
disuse (26) and this is confirmed in the current study. The
findings of our study suggest that resveratrol may modestly
improve the apoptotic environment of muscles in aged rodents
during reloading following disuse, but it has a limited ability to
alter satellite cell proliferation as a mechanism for recovering
muscle mass that was lost during the period of disuse.
Methods
Animals
Thirty-six male Fisher 344 × Brown Norway rats were
obtained from the National Institute on Aging (NIA) colony that
is housed at Harlan (Indianapolis, IN). All of these animals
were 32 months of age. The animals were housed at 20°C in
barrier-controlled conditions under a 12:12 hour light-dark
cycle. Proper animal care standards were followed by adhering
to the recommendations for the care of laboratory animals as
advocated by the American Association for Accreditation of
Laboratory Animal Care and by following the policies and
procedures detailed in the Guide for the Care and Use of
Laboratory Animals as published by the U.S. Department of
Health and Human Services and proclaimed in the Animal
Welfare Act (PL89-544, PL91-979, and PL94-279). All
experimental procedures carried approval by the Institutional
Animal Care and Use Committee from the West Virginia
University.
Hindlimb suspension
The animals were randomly assigned to ambulatory cage
control (n=12), hindlimb suspended (n=12), or reloaded after
suspension (recovery; n=12) groups. The hindlimb suspension
lasted fourteen days as previously described [25]. Briefly,
orthopedic tape was applied along the proximal one-third of the
animals’ tail and then placed through a wire harness attached
to a swivel. This was fixed to the top of a specially designed
hindlimb suspension cage which provided the rats with 360° of
movement around the cage. The forelimbs maintained contact
with a grid pattern floor, allowing the animals to move, groom
themselves, and obtain food and water freely. The exposed tip
of the tail was closely monitored to ensure that it remained
pink, indicating that hindlimb suspension did not interfere with
blood flow to the tail. The suspension height was monitored
and adjusted to prevent contact between the hindlimbs and any
supportive surface of the cage. Care was taken so that the
suspension angle of the torso of the animals to the cage floor
did not exceed 30°. All animals were weighed prior to and
following the suspension period to determine total body mass
changes. Furthermore, the recovery animals were released
from suspension after the fourteen day protocol and provided
an additional fourteen days of normal ambulation, at which
point they were weighed and sacrificed.
Nutritional treatment
Beginning one week prior to suspension, the rats received
1ml of 0.1% carboxymethylcellulose dissolved in distilled water
(vehicle treated), and the remaining eighteen rats received 1ml
of trans-resveratrol suspended in 0.1% carboxymethylcellulose
dissolved in distilled water (resveratrol treated), administered
via oral gavage daily throughout the study. Previous studies in
our lab [19,26] using resveratrol (12.5 mg/kg/day in the diet, or
50 mg/kg/day by oral gavage) were too low to effectively
preserve muscle mass. Therefore, in this study resveratrol was
administered at a dose of 125 mg/kg/day in this study in order
to increase the likelihood of detecting the effects of this
compound on muscle wasting and regeneration. This provided
a bolus increase in resveratrol every 24 hours. To ensure
resveratrol was also available systemically throughout the day,
the resveratrol treated animals were given food pellets that
contained 0.05% resveratrol. Vehicle treated animals had an
identical diet to the resveratrol treated animals, but their chow
did not contain resveratrol. This provided a mechanism to
provide a more consistently high level of resveratrol throughout
the day. Food and water was provided ad libitum.
Bromodeoxyuridine administration
Immediately following suspension, each of the recovery
animals received a 200mg bromodeoxyuridine (BrdU; 5-
bromo-2’-deoxyuridine) pellet (21-day release; Innovative
Research; Sarasota, FL) in order to analyze myonuclear
(satellite cell) proliferation, as BrdU is a thymidine analog which
is incorporated into nuclei during DNA synthesis. Upon release
from suspension, a small incision was made in the upper back
Resevartrol and Muscle Recovery Following Disuse
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of anesthetized animals whereupon the BrdU pellet was
inserted subcutaneously. The incision was closed with a wound
clip (MikRon Autoclip 9 mm; Becton Dickinson; Sparks, MD)
and the animals were allowed to recover from anesthesia
before being returned to their cage.
Research design
Muscle data were obtained from both the resveratrol and
vehicle-treated animals after hindlimb suspension, or recovery.
In addition, two groups of ambulatory non-suspended cage
control animals were used. Six cage control animals were
examined 21 days after the initiation of the study. These
animals acted as controls for the hindlimb suspension groups.
A second group of six cage control animals were examined 35
days after the initiation of the study and were used as controls
for the recovery groups. Among the suspended animals, six per
diet group (i.e., vehicle or resveratrol) were sacrificed 21 days
after the initiation of the study (hindlimb suspension) and
another six animals per diet group were sacrificed 35 days after
the initiation of the study (recovery). The six hindlimb
suspension cage control and six recovery cage control animals
were also sacrificed at these respective time points.
Tissue collection
At the end of the 21 and 35 day experimental periods for the
hindlimb suspension and recovery groups respectively, the
animals were sacrificed while under deep anesthesia (5%
Isoflurane/95% Oxygen). The soleus, gastrocnemius, and
plantaris muscles were excised from both hind limbs, blotted to
remove excess fluid, and individually weighed. The weight of
each muscle was normalized to the animals’ body weight and
subsequently compared to determine if resveratrol preserved
muscle mass. A block obtained from the mid-belly of the
muscle was embedded in optimal cutting temperature (OCT)
compound, flash frozen in liquid nitrogen cooled isopentane,
and stored at -80°C until later analyses. Blood samples were
obtained from the left ventricle of each animal via a stainless
steel needle (19G1½; Becton Dickinson; Rutherford, NJ). The
concentration of resveratrol was determined in the serum
samples by high-performance liquid chromatography against
known standards (Protea Biosciences, Inc.; Morgantown, WV).
Following blood collection, the animals were immediately
euthanized by removing the heart with surgical scissors.
Resveratrol and metabolites of resveratrol in plasma
Plasma from resveratrol and control animals was analyzed
for resveratrol and its metabolites: Trans-Resveratroi-3-0-
Sulfate, Trans-Resveratroi-3-0-Giucuronide, and Trans-
Resveratroi-4-0-Giucuronide. Plasma was analyzed by Protea
Biosciences (Morgantown, WV) using high performance liquid
chromatography (HPLC). Quantification of the data was made
against standard curves (generated in duplicate) for each
metabolite.
Sirt1 activity
Sirt1 activity was measured in total plantaris muscle
homogenates using a fluorescent deacetylase substrate using
a commercially available kit (BML-AK555; Enzo Life Sciences
Inc.; Farmingdale, NY). Briefly, muscles were homogenized in
ice-cold distilled water and the protein concentrations were
determined using a DC protein concentration assay (BioRad).
The tissue samples were diluted to 2.5 μg/μL using the
reagents supplied in the kit. The fluorescent substrate, in
conjunction with 100 μM of the co-substrate NAD+, was then
incubated with 15 μL of each sample for 45 minutes at room
temperature (RT) in a ½ volume 96-well white microplate. Once
complete, 2mM nicotinamide (a Sirt1 inhibitor) and the provided
fluorescent developer were added to each well to halt the
reaction and produce a fluorophore which is linearly related to
Sirt1 activity. The intensity of the fluorescent signal was
detected with an excitation wavelength of 360 nm and an
emission wavelength of 460 nm. Data are presented as
fluorescent units normalized to the respective milligrams of
protein used in each homogenate.
Ex vivo muscle physiological analyses
Isometric muscle contractile properties were examined in the
plantaris muscles from the left leg of all experimental animals.
The muscles were placed in an oxygenated Ringer’s solution
(137 mM NaCl, 4.7 mM KCl, 3.4mM CaCl2, 1.2mM MgSO4, 1
NaH2PO4, and 112 D-glucose), which was maintained at 20°C.
The Ringer’s solution was aerated with 95% O2 and 5% CO
(pH 7.4). The distal end of the muscle was attached to a
stationary plexiglass plate, and the proximal end fixed to the
lever arm of a 300C dynamometer (Aurora Scientific, Aurora
Ontario, Canada). The muscles were stimulated by passing a
constant current through platinum plates positioned on each
side of the muscle. Ex vivo isometric twitch and tetanic
contractions were obtained using a Constant Current/Constant
Voltage Stimulator (Aurora Scientific) that provided DC-square
wave signals at a stimulation current of 12 Volts, with a 200 µs
pulse width. Muscles were adjusted to the optimal muscle
length (Lo) by a micromanipulator that controls the base
position of the electrode clamp. Lo was established as the
muscle length that produced maximal isometric twitch tension
and was periodically checked by the same procedure
throughout each experiment to maintain this length. Force-
frequency isometric force records were obtained by stimulating
the muscle at 10, 20, 40, 50, 75 and 100 Hz, with 3 minutes of
rest between each contraction. Physiological contractile
measures included peak isometric twitch force (PT), time to
peak twitch contraction tension (CT), and the ½ relaxation time
of twitch contraction (½ RT), as previously described [27].
Following isometric contractions, the muscles remained in the
oxygenated Ringer’s solution for 5 minutes prior to the
repeated stimulation fatigue protocol. Muscle fatigue was
assessed by stimulating the muscle at 40Hz for 3 minutes
utilizing a duty cycle of 330 ms of stimulation followed by 660
ms of rest [28]. The fatigue index was calculated as the force
from the last contraction expressed as a percentage of the
force obtained on the first contraction. The contractile and
fatigue measurements were analyzed off line using commercial
software (DMI, Aurora Scientific).
Resevartrol and Muscle Recovery Following Disuse
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Fiber characteristics
Muscle fiber type and cross-sectional area (CSA) analyses
were performed in the plantaris muscles. Frozen tissue cross
sections measuring 10-μm thick were cut from the mid-belly of
the muscles, mounted on charged microscope slides (Fisher
Scientific; Pittsburgh, PA), and stored at -80°C. For analysis,
the slides were air-dried 30 minutes, washed in PBS, and
incubated for 30 minutes at RT with 4% bovine serum albumin
in PBS. The tissue sections were incubated overnight at 4°C
with antibodies directed against laminin (MAB1914; Millipore;
Temecula, CA) to visualize the basal lamina of each muscle
fiber, as well as one of the following individual myosin heavy
chain (MyHC) antibodies: BA-D5 (for MyHC I; Developmental
Studies Hybridoma Bank; Iowa City, IA), SC-71 (for MyHC IIA;
DSHB), and BF-F3 (for MyHC IIB; DSHB) in order to determine
both the whole muscle composition and mean cross-sectional
area (CSA) for each respective fiber type. The next day, the
slides were washed in PBS and incubated 1 hour at 37°C with
secondary antibodies of donkey anti-rat rhodamine conjugate
(712-025-150; Jackson ImmunoResearch Laboratories; West
Grove, PA) to visualize the basal lamina, and Alexa Fluor 488
(A10680; Invitrogen; Eugene, OR) to visualize the MyHC
expression in the muscle fibers. The sections were mounted
with 4', 6-diamidino-2-phenylindole (DAPI) (Vectashield
Mounting Medium; Vector Laboratories; Burlingame, CA) to
visualize the nuclei. Four images from non-overlapping regions
of each tissue cross-section stained for individual MyHC fibers
were used to determine both fiber type proportions and
respective CSA’s. All images were taken with a Zeiss LSM 510
Meta confocal microscope (Carl Zeiss Microimaging Inc.;
Thornwood, NY) at a magnification of 20X. Mean fiber CSA of
respective fiber types was determined by planimetry and
calculated by the ImageJ software (NIH; Frederick, MD). Fiber
types are expressed as a proportion of MyHC-positive fibers to
total fibers for each individual MyHC examined. The
percentage of type IIX MyHC fibers was calculated from fibers
that were negative to type I, IIA, and IIB MyHC antibodies.
Western blotting
Western blots were used to determine the relative amount of
proteins in apoptotic signaling pathways following hindlimb
suspension and recovery. Approximately seventy-five
micrograms of muscle was homogenized in ice-cold modified
RIPA buffer (50mM Tris, 1% NP-40, 150mM NaCl, 1mM EDTA,
0.1% SDS, 0.5% Na-deoxycholate; pH: 7.4) containing
protease and phosphatase inhibitors. The muscle
homogenates were centrifuged at 1,000g for 5 minutes at 4°C,
and the resulting supernatant was collected. The protein
content of the samples was measured using the DC protein
assay kit (BioRad; Hercules, CA). Thirty-five micrograms of
protein was loaded into each well of a 4-12% gradient
polyacrylamide gel (Invitrogen; Carlsbad, CA) and separated
by routine sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) for 2 hours at 135V. The proteins
were then transferred to a nitrocellulose membrane for 2 hours
at 35V. Non-specific protein binding was blocked by incubating
the membranes in 5% nonfat milk in Tris-buffered saline
containing 0.05% Tween 20 (TBST) at RT for 1 hour.
Membranes were incubated overnight at 4°C on a rocking table
with primary antibodies (1:1,000) directed against Bcl-xL
(#2762; Cell Signaling Technology; Boston, MA), Bax (#2772;
Cell Signaling) Bcl-2 (#2876; Cell Signaling), cleaved caspase
3, (#9664; Cell Signaling), cleaved caspase 9 (#9507; Cell
Signaling), AMPK (#5832; Cell Signaling), pAMPK (#2535; Cell
Signaling), Sirt1 (#9475; Cell Signaling) and PGC1(#sc-13067;
Santa Cruz Biotech; Dallas, TX). Furthermore, a primary
antibody (1:2,000) was directed against GAPDH (ab8245;
Abcam; Cambridge, MA) for use as a loading control. The
following day, the membranes were washed in TBST and
incubated in appropriate dilutions of secondary antibodies
(diluted in 5% non-fat milk) conjugated to horseradish
peroxidase for one hour at RT on a rocking table. The signals
were developed using a chemiluminescent substrate (Lumigen;
Southfield, MI) and visualized by exposing the membranes to
x-ray film (BioMax MS-1; Eastman Kodak, Rochester, NY).
Digital records of the bands were captured using a Kodak 290
camera and quantified using one-dimensional analysis
software (Eastman Kodak) as optical density × band area,
expressed in arbitrary units relative to appropriate loading
controls.
Identification of apoptotic nuclei
Frozen tissue 10-μm thick cross sections were obtained from
the plantaris muscles and mounted on charged microscope
slides (Fisher Scientific; Pittsburgh, PA). Fluorescent labeling
of terminal dUTP nick-end labeling (TUNEL) with lamina
allowed the detection of apoptotic nuclei in the muscle
sections. This was accomplished using a slight modification to
the method previously reported for our lab [29]. Briefly, the
tissue sections were air dried, fixed with 4% paraformaldehyde,
and permeabilized with 0.2% Triton X-100 in PBS for 30
minutes each at room temperature. The tissues were incubated
overnight at 4°C in a rat anti-lamina monoclonal antibody
(Millipore). Sections were incubated the following day with
donkey anti-rat rhodamine conjugated secondary antibody
(Jackson ImmunoResearch), along with the TUNEL reaction
mixture (11-684-795-910; Roche Diagnostics; Indianapolis, IN)
in a humidified chamber at 37°C for 1 hour in the dark. The
exclusion of the TdT enzyme in the TUNEL reaction mixture on
one of the tissue sections on each slide was included as a
negative control. The sections were mounted with DAPI
(Vectashield) in order to visualize nuclei and viewed under a
Zeiss LSM 510 Meta confocal microscope (Carl Zeiss
Microimaging Inc.; Thornwood, NY). The number of TUNEL
and DAPI-positive nuclei that were immediately adjacent to, or
beneath the basal lamina were counted. The data are
expressed as an apoptotic index, calculated as the percentage
of TUNEL-positive nuclei out of the total myonuclei (i.e., DAPI-
positive nuclei) pool. The apoptotic index was determined from
four non-overlapping regions of each tissue cross section
visualized with a 20X objective.
BrdU detection
Frozen tissue cross sections measuring 10-μm thick from the
plantaris muscle were mounted on charged microscope slides
(Fisher Scientific; Pittsburgh, PA). Briefly, tissue sections were
Resevartrol and Muscle Recovery Following Disuse
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air dried, washed in PBS, fixed in methanol: acetone (1:1) at
-20°C for 5 minutes, and permeabilized with 0.4% Triton X-100
in PBS. Sections were then denatured, blocked with serum and
incubated overnight in a biotinylated mouse anti-BrdU primary
antibody (HCS30, EMD Biosciences, Inc., La Jolla, CA). On the
following day, the sections were incubated with a secondary
antibody of Fluorescein Avidin DCS (A-2011; Vector
Laboratories, Inc.; Burlingame, CA) and subsequently blocked
in normal goat serum. They were then incubated overnight in a
rat anti-lamina monoclonal (Millipore) primary antibody. The
tissue sections were incubated the following day with a donkey
anti-rat rhodamine conjugated (Jackson ImmunoResearch)
secondary antibody in a humidified chamber at 37°C for 1 hour
in the dark. Finally, the sections were mounted with 4',6-
diamidino-2-phenylindole (DAPI)-containing mounting medium
(Vectashield) in order to visualize nuclei. Immunofluorescence
was visualized with a Zeiss LSM 510 Meta confocal
microscope (Carl Zeiss). Images were taken from four non-
overlapping regions of each tissue section with a 20X objective.
Statistical analysis
All results are reported as means ± SD. Differences in
means between groups were determined by multiple analysis
of variance (MANOVA) Hotelling's T-Square test. Bonferroni
post hoc analyses were subsequently performed between




We measured the bodyweight of all animals at the beginning
of the one-week pretreatment period (Start), immediately prior
to suspension (Day 0), following hindlimb suspension, and
following the recovery period. There were no differences in
bodyweight between any of the groups at the beginning of the
experimental protocol. Furthermore, no significant changes in
bodyweight were observed in the cage control animals at any
of the time points. A significant loss of bodyweight occurred in
all of the suspended animals as compared to the first day
(Start) of the experiment, with decreases of 24.6% and 18.0%
observed in the vehicle and resveratrol treated groups,
respectively. These significant losses continued into the
recovery period as well, with vehicle and resveratrol treated
animals losing an additional 3.7% and 5.6% of body mass,
respectively, between the end of hindlimb suspension and the
end of the recovery period. However, resveratrol was unable to
attenuate any of these bodyweight reductions, as there were
no significant differences observed between the vehicle and
resveratrol treated animals at any of the individual time points
of the study (Figure 1A).
Muscle wet weight
Upon sacrifice, the plantaris muscle wet weights were
examined to assess changes in muscle mass following the
suspension and recovery periods. As expected, hindlimb
suspension induced significant decreases (P<0.001) in
absolute muscle mass in both the vehicle and resveratrol
treated groups as compared to the hindlimb suspension control
animals (Figure 1B). However, there were no differences
between the vehicle and the resveratrol treated animals.
Following the recovery period, the wet weights from both the
vehicle treated animals was still suppressed but the muscle
weight of the resveratrol treated animals fully recovered to that
of the control animals’ muscle mass.
Muscle contractile characteristics
Plantaris muscles were attached to a force transducer in
oxygenated Ringers solution, to determine various muscle
contractile properties following hindlimb suspension and
recovery. Following hindlimb suspension, there was a
significant increase (P<0.001) in CT during a twitch contraction
in both the vehicle (78.6 ± 5.3 ms) and resveratrol (86.2 ± 10.6
ms) treated groups as compared to the cage controls (38.7 ±
6.8 ms). However, resveratrol was unable to attenuate this
increase (Figure 2A). In the recovery group, the CT of both the
vehicle (78.0 ± 6.4 ms) and resveratrol (86.2 ± 10.6 ms)
animals was significantly greater than that of the recovery cage
control (62.0 ± 8.0 ms) animals (Figure 2B). There were no
differences observed when comparing the CT of the vehicle
and resveratrol treated animals.
Next, we examined the ½ RT during a twitch contraction. In
the hindlimb suspension group, the ½ RT was significantly
shorter in the vehicle treated (47.4 ± 11.8 ms) animals
compared to either the resveratrol (65.8 ± 7.8 ms) or cage
control (69.8 ± 9.6 ms) groups (Figure 2A). Moreover, there
were no differences between the resveratrol and cage control
groups at this time point. This same trend also continued into
the recovery period (Figure 2B). While there were no
differences in the ½ RT between the resveratrol (71.3 ± 18.1
ms) and cage control (61.2 ± 13.0 ms) groups, the ½ RT of the
vehicle treated (42.7 ± 3.8 ms) group was significantly shorter
than both of these two groups.
Lastly, we plotted the force-frequency curve for the hindlimb
suspension and recovery groups. In the hindlimb suspension
animals, a frequency of 20 Hz produced a significant rightward
shift in both the vehicle and resveratrol treated groups (Figure
3A). At 50 Hz, there remained a significant rightward shift in the
resveratrol animals curve compared to both the cage control
and vehicle treated animals. In contrast, there were no
differences observed between the vehicle treated and cage
control groups. At 75 Hz, both the vehicle and resveratrol
treated groups reached their peak relative forces.
In the recovery animals, the force frequency curves from
both the vehicle and resveratrol treated groups were
significantly shifted to the right of the cage control curve at 10,
20, and 50 Hz (Figure 3B). However, the force-frequency
curves of the vehicle and the resveratrol groups did not differ.
The force record at 75 Hz in the resveratrol treated animals
had a significant rightward shift as compared to the cage
controls.
Muscle fatigue characteristics
The fatigue index was examined in order to determine if
resveratrol had improved the muscles fatigue tolerance during
Resevartrol and Muscle Recovery Following Disuse
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a series of contractions. As expected, hindlimb suspension
elicited a significant decrease in the muscles’ resistance to
fatigue. Both the vehicle (11.3 ± 2.6%) and the resveratrol
(11.6 ± 2.9%) treated animals had significantly reduced fatigue
indexes as compared to the cage control (16.6 ± 1.8%) group
(Figure 4). However, there were no differences observed
between the resveratrol and the vehicle treated animals. In the
recovery animals, the vehicle treated animals had a similar
fatigue index (10.9 ± 1.6%) as the resveratrol (9.5 ± 1.8%) fed
group; however the fatigue index of the resveratrol group was
significantly lower than the cage control (14.8 ± 4.8%) group
after reloading (Figure 4).
Sirt1 activity
Plasma resveratrol and it’s metabolites were determined by
HPLC analysis. The plasma level of resveratrol, in resveratrol-
Figure 1.  Body and muscle wet weights.  A) Bodyweight measurements of all animals were taken immediately prior to the start of
the one-week pretreatment period (Start), prior to suspension (0), following hindlimb suspension (HS), and again following the
reloading period recovery in cage control (n=12), vehicle-treated (n=12) or resveratrol-treated (n=12) animals. B. Plantaris muscle
wet weights were obtained following HS or R. * P<0.05 vs. cage control.
doi: 10.1371/journal.pone.0083518.g001
Resevartrol and Muscle Recovery Following Disuse
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e83518
treated animals averaged 400.3 ± 69.9 ng/ml at the point of
sacrifice. There were no differences between the animals in the
hindlimb suspension or control groups. Metabolites of
resveratrol were similarly very high in the resveratrol treated
animals (Table S1). While there were no traces of resveratrol in
the plasma of any of the vehicle treated animals, there was a
detectible about of several resveratrol metabolites in the
plasma of vehicle treated animals (Table S1) suggesting that
Figure 2.  Plantaris muscle twitch characteristics.  Muscle twitch contractile properties including CT and ½ RT were analyzed in
the plantaris muscles of both the hindlimb suspension (A) and recovery (B) groups. Each data point represents the average of three
measures. * P<0.05 vs. cage control; † P<0.05 vehicle vs. resveratrol.
doi: 10.1371/journal.pone.0083518.g002
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perhaps the control diet contained small but detectable levels
of resveratrol which had been metabolized by the vehicle-
treated animals.
The relative activity of Sirt1 in the plantaris muscles of all of
the animals was assessed using a fluorometric assay. In the
hindlimb suspension animals, there were no significant
differences in Sirt1 activity between any of the groups, although
Figure 3.  Force-frequency relationship.  A force-frequency curve was plotted for both the hindlimb suspension (A) and recovery
(B) groups. Each force-frequency measurement was made three times with a minimum of 5 minutes rest between each contraction,
and the average of the three trials was recorded for each animal. * P<0.05 vehicle and resveratrol vs. cage control; † P<0.05 vehicle
vs. resveratrol.
doi: 10.1371/journal.pone.0083518.g003
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there was a trend towards higher levels in the resveratrol
treated animals (Figure 5). This trend continued with the
recovery groups as well, although the differences between the
groups were less than it was in the hindlimb suspension
animals. This was due to a slight elevation in Sirt1 activity in
the muscles of both the recovery control and the vehicle
treated animals as compared to their respective hindlimb
suspension groups.
Resveratrol treatment elevated AMPK and pAMPK
abundance in the plantaris of resveratrol-fed animals in the
recovery group as compared to the vehicle treated or control
animals (Figure 5). Sirt1 protein abundance was not improved
by resveratrol treatment (Figure 5). However, resveratrol,
appeared to increase the protein abundance of PGC1α, a
downstream target of Sirt1, in the plantaris muscles of animals
in the recovery group fed resveratrol, as compared to vehicle
treated animals. We did not determine if mitochondrial
biogenesis had been altered by resveratrol treatment in the
muscles of these animals, however, this seems unlikely since
the fatigue characteristics of the muscles was not improved by
resveratrol treatment.
Myosin heavy chain profile
The myosin heavy chain expression was identified in the
plantaris muscles fibers by immunocytochemistry (Figure 6).
This provided both an index of fiber type and also fiber size.
Typically, hindlimb suspension results in a shift from type I to
type II fibers. To determine if resveratrol reduced this fiber type
shift following hindlimb suspension or recovery, we examined
the myosin heavy chain (MyHC) profile of the plantaris
muscles. Following hindlimb suspension, the relative
percentage of type I MyHC fibers was significantly reduced in
both of the groups subjected to suspension. However, there
were no differences between MyHC composition in the vehicle
and the resveratrol treated animals, although the mean
percentage was slightly higher in the resveratrol group (Figure
7A). The resveratrol treated animals in the hindlimb suspension
group, had a greater percentage of type IIA MyHC fibers, than
either the vehicle treated suspended animals, or cage control
animals. Suspension significantly increased the percentage of
type IIB fibers, although resveratrol had no effect on changes in
this fiber type compared to the vehicle treatment. In contrast,
the percentage of type IIX MyHC fibers was significantly
reduced after suspension in the resveratrol treated animals
from that of the control muscles. However, there were no
significant differences between the two suspended groups.
Figure 4.  Fatigue index.  Plantaris muscle fatigability was expressed as a fatigue index, and calculated as the percent of the initial
force ( average of the first three contractions, divided by the force at the end of the fatigue protocol (an average of the force
generated in the final three contractions) in a series of 128 consecutive contractions. * P<0.05 vs. cage control; † P<0.05 vehicle vs.
resveratrol.
doi: 10.1371/journal.pone.0083518.g004
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The percentage of type I fibers remained significantly less in
the animals in the recovery group that had previously been
suspended. However, there was an increase in the percentage
of type I fibers in the vehicle treated animals to where the
resveratrol treated animals no longer had a greater proportion
of this fiber type (Figure 7B). While the percentage of type IIB
fibers remained significantly elevated in both the vehicle and
the resveratrol treated animals in the recovery group as
compared to the control group, there remained no differences
between these treatment groups. There was no difference
between the percentage of type IIX MyHC fibers in the
recovery group of resveratrol and the vehicle treated animals.
Fiber size
Muscle fiber CSA was determined by planimetry in type I,
IIA, and IIB MyHC fibers (Figure 6). As expected, hindlimb
suspension induced significant muscle atrophy in all of the fiber
types examined. There were no differences in mean type I fiber
CSA between the vehicle and resveratrol treated animals after
hindlimb suspension, although both hindlimb suspension
treatment groups had significantly smaller fibers than the cage
control animals. In type IIA fibers, only the vehicle treated
animals had myofibers with mean CSA’s significantly smaller
than that of the cage control animals (Figure 8A). The mean
fiber CSA from the resveratrol treated animals in the hindlimb
suspension group was not different than the cage control
animals, indicating that resveratrol partially preserved muscle
fiber area during hindlimb suspension in this particular fiber
type. Type IIB MyHC fibers CSA was significantly smaller in
both the vehicle and the resveratrol treated groups as
compared with the fiber CSA from cage control animals.
However, no significant differences were noted between type
Figure 5.  Resveratrol-induced metabolic signaling in the plantaris muscle.  A. Western blots were conducted for plantaris
muscles after hindlimb suspension or following recovery from hindlimb suspension. The protein content was measured in total
plantaris muscle homogenates via immunoblotting. Total muscle protein lysates were separated on a 4-12% gradient
polyacrylamide gel by routine SDS-PAGE. The proteins were electroblotted to nitrocellulose membranes and the signals were
developed by chemiluminescence. The proteins included phosphorylated (activated) AMPK, total AMPK, PGC1α, and Sirt1. GAPDH
was used as an internal loading control. Con, control; Veh, vehicle-treated; Res, resveratrol treated.
B-E. The digital images of the western blots were quantified as optical density x band area using ImageJ software and normalized to
GAPDH, which was used as the loading control for each lane. The data include: B, total AMPK; C. phosphorylated AMPK (pAMPK);
D. PGC1α; and E. Sirt1. The data are expressed as the protein signal to the GAPDH signal and are reported as mean ± SEM in
arbitrary units. A minimum of three western blots were completed for each protein, and the data were averaged for each animal.
F. Sirt1 enzyme activity was determined fluorometrically in plantaris muscle homogenates. Data are expressed as arbitrary
fluorescent units (AFU)/µg protein. * P<0.05 vs. cage control; †P<0.05 vehicle vs. resveratrol.
doi: 10.1371/journal.pone.0083518.g005
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IIB fiber CSA in the vehicle and resveratrol treated groups
following hindlimb suspension.
Animals in the recovery group had a similar fiber type pattern
as was found in muscles from the hindlimb suspension animals
(Figure 8B). This suggests that there was no substantial return
to control levels in fiber type distribution during the recovery
period. Specifically, type I fibers CSA remained significantly
smaller in both the vehicle and resveratrol treated animals as
compared to the cage controls. Mean type IIA fiber CSA was
significantly reduced in the vehicle treated animals as
compared to the cage control animals. While the mean CSA of
the resveratrol treated animal’s fibers were not statistically
different than the vehicle treated animals, the reduction in
myofiber size from control levels appeared to be partially
attenuated with resveratrol treatment, as these differences did
not reach significance. Moreover, although the mean type IIB
fiber CSA remained significantly reduced in the vehicle treated
animals, the mean CSA of the resveratrol treated animals
somewhat recovered and so that fiber CSA was no longer
statistically smaller than the control fibers.
BrdU incorporation
A BrdU pellet was implanted subcutaneously at point that
hindlimb suspension was removed, in each of the recovery
animals to identify satellite cells that had proliferated during the
regenerative period following hindlimb suspension. BrdU-
positive nuclei were expressed per 100 myonuclei. BrdU
incorporation was very low in muscles of the cage control
animals (0.34 ± 0.61). Presumably, there was minimal stimulus
to activate any available satellite cells from quiescence under
these homeostatic conditions (Figure 9). It was not surprising
that there was a significant increase in BrdU incorporation in
both the vehicle (7.8 ± 3.2) and resveratrol (11.0 ± 3.5) treated
animals during the recovery period, as satellite cells were
activated upon reloading, presumably in an attempt to recover
the muscle mass lost during hindlimb suspension. While there
was a trend for slightly more BrdU positive nuclei in resveratrol
treated muscles, this was not significantly different from the
vehicle group.
Apoptotic signaling
We have previously characterized apoptotic protein changes
during hindlimb suspension and reloading [13,30]. In the
current study, western blots were used to determine the
relative content of anti-apoptotic Bcl-xL and Bcl-2 and pro-
apoptotic Bax, cleaved caspase 3 and cleaved caspase 9
proteins, as representative of changes in the apoptotic
signaling pathway. Protein levels of the respective proteins
Figure 6.  Muscle fiber immunocytochemistry.  Frozen tissue cross sections were incubated overnight at 4°C with antibodies
directed against the basal lamina (red) and myosin heavy chain I, IIA, or IIB (green). The sections were counterstained with DAPI
(blue) to identify the nuclei. Digital images were taken with a confocal microscope. This figure provides a representative example of
a section stained for type I myosin heavy chain that was used to measure fiber type composition and CSA analyses for this fiber
type in both the hindlimb suspension and recovery groups. Green fibers are positive for type I myosin heavy chains. Scale bars
represent 50 µm. * P<0.05 vs. cage control; † P<0.05 vehicle vs. resveratrol.
doi: 10.1371/journal.pone.0083518.g006
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were normalized to GAPDH protein levels and were expressed
in arbitrary units. Although resveratrol did not reduce the
hindlimb suspension-induced elevation in Bax, in the recovery
group, the pro-apoptotic Bax protein abundance was lower in
resveratrol than vehicle treated plantaris muscles (Figure 10).
In a similar pattern, pro-apoptotic proteins cleaved caspase 3
and cleaved caspase 9 were elevated by hindlimb suspension,
but the increases in cleaved caspase 9, a mitochondrial-
associated pro-apoptotic protein was suppressed by
resveratrol. Resveratrol suppressed both cleaved caspase 3
and cleaved caspase 9 in the plantaris muscles of the recovery
group as compared to the vehicle treated group (Figure 10).
Bcl-2 was elevated in a similar fashion in vehicle treated and
resveratrol treated plantaris muscles during hindlimb
suspension (Figure 10). During recovery, the Bcl-2 protein
abundance returned to control levels in the vehicle-treated
plantaris muscle, but it remained elevated in plantaris muscles
that were treated with resveratrol. The protein abundance of
the anti-apoptotic Bcl-xL was significantly increased in the
resveratrol group following hindlimb suspension, while no
changes were observed in the vehicle (0.20 ± 0.16) treated
group as compared to the cage control (0.28 ± 0.11) animals
(Figure 10). During recovery, the abundance of Bcl-xL was
elevated in both the vehicle (0.83 ± 0.11) and resveratrol (0.91
Figure 7.  Muscle fiber myosin heavy chain composition and morphology.  Immunocytochemical stained plantaris muscle
fibers for myosin heavy chains, from control, vehicle-treated and resveratrol-treated rats were analyzed for their myosin heavy chain
fiber composition in both the hindlimb suspension (A) and recovery (B) groups. * P<0.05 vs. cage control.
doi: 10.1371/journal.pone.0083518.g007
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± 0.09) treated animals, although there were no differences
observed between these two groups (Figure 10).
To complement the western blot analysis, we used a TUNEL
assay to confirm the relative amount of myonuclei undergoing
apoptosis immediately following hindlimb suspension (Figure
11A) and recovery (Figure 11B). Consistent with our previous
observations [13,30], there was a significant increase in
apoptosis following hindlimb suspension (Figure 11C). While
insignificant, the mean increase in the apoptotic index was 29%
higher in the vehicle (1.35 ± 0.49) treated animals compared to
the resveratrol (0.96 ± 0.50) treated animals. In the recovery
group, the TUNEL index remained significantly elevated in both
the vehicle (1.90 ± 0.50) and resveratrol (1.42 ± 0.90) treated
animals.
Discussion
Recovery of skeletal muscle mass after immobilization-
induced atrophy is difficult or impossible in aged animals or
humans [8–10], but it is more complete in younger hosts.
Therefore, the focus of our study was to examine the efficacy
of resveratrol to improve muscle recovery following disuse in
Figure 8.  Muscle fiber cross sectional area.  Mean fiber cross sectional area (CSA) measurements were obtained from a
minimum of 500 fibers in each muscle for plantaris muscle fibers that expressed type I, IIA, or IIB myosin heavy chains in hindlimb
suspension (A) and recovery (B) groups. Four images from non-overlapping regions of each tissue cross-section stained for
individual MyHC fibers were used for muscle fiber CSA measures. All images were taken with a Zeiss LSM 510 Meta confocal
microscope at a magnification of 20X. Mean fiber CSA of respective fiber types was determined by planimetry. * P<0.05 vs. cage
control.
doi: 10.1371/journal.pone.0083518.g008
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aging, and therefore we were not interested in identifying
differences in response between young and old animals. In this
study, resveratrol treatment failed to prevent the loss of
plantaris muscle mass in old rats during 14 days of hindlimb
suspension. However, resveratrol treatment enhanced the
recovery of plantaris muscle mass during reloading after the
period of disuse. The mechanism for resveratrol’s effect on
muscle recovery after disuse appeared to be at least partially
through a suppression of pro-apoptotic proteins and an
increase in the abundance of anti-apoptotic proteins in
reloaded muscles of resveratrol-treated animals as compared
to vehicle-treated animals. Thus, it is possible that the lower
apoptotic environment may have contributed to more total
surviving myonuclei (by having a small increase in proliferation
and less death of the new nuclei) and therefore provided a
greater potential for nuclear regulation of muscle repair.
Muscle and muscle fiber responses to resveratrol
during reloading
As expected [13,19,31–33], a fourteen day period of hindlimb
suspension induced significant reductions in plantaris muscle
weights of the aged animals; however, resveratrol did not
prevent or slow muscle wasting in response to disuse in the old
rats that were examined in this study. This was an unexpected
finding because a high dose (400 mg/kg) of resveratrol has
been shown to protect soleus muscles from hindlimb
suspension-induced atrophy [18], and we had previously found
a strong trend (p=0.06) for a lower dose of resveratrol (12.5
mg/kg) to reduce disuse atrophy in the rat gastrocnemius
muscles from old rats [19]. Furthermore, we increased the
intake levels of resveratrol from our earlier study to 125
mg/kg/day in this study, expecting that the greater level would
increase the potential for improving muscle recovery after
unloading. While resveratrol and its metabolites were clearly
present in plasma of treated animals that were examined in the
current study (Table S1), and AMPK, pAMPK and PGC1α were
all greater during the recovery period in the plantaris muscles
of animals fed resveratrol as compared to vehicle fed animals
(Figure 5), this dose of resveratrol may still not have been high
enough to provide any significant sparing of muscle mass
during hindlimb suspension. Nevertheless, these metabolic
changes appeared to be adequate to provide modest but
significant improvements in muscle mass and muscle fiber
recovery as compared to vehicle-treated animals after
resuming ambulation. Thus, it is likely that the protective effects
of resveratrol against disuse atrophy and/or muscle growth to
recover from disuse are muscle and/or dose specific. This may
indeed be the case because resveratrol was unable to
attenuate the hindlimb suspension-induced decreases during
Figure 9.  Proliferation of satellite cells.  In order to analyze satellite cell proliferation during the reloading period, a time-released
BrdU pellet was inserted into the recovery animals at the point that they were released from suspension. BrdU is a thymidine
analogue and it was incorporated into muscle nuclei (satellite cells) that divided.
A. A representative section from the plantaris of a resveratrol-treated animal that was reloaded for 14 days following 14 days of
hindlimb suspension. The tissue was stained with DAPI to identify all of the nuclei, an anti-BrdU antibody to identify nuclei that had
proliferated, and an anti-laminin antibody to identify the basal lamina. The overlay shows the three fluorescent images
superimposed. The expanded insert shows examples of BrdU positive nuclei that are co-localized to the DAPI stained myonuclei
over the basal lamina (white arrows). Other examples of non-specific (green) staining not on nuclei are evident, but they were not
included in the quantification of BrdU positive nuclei.
B. BrdU incorporation in muscle nuclei (i.e., proliferated satellite cells) is expressed as the number of BrdU-positive nuclei per one
hundred myonuclei. * P<0.05 vs. cage control.
doi: 10.1371/journal.pone.0083518.g009
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hindlimb suspension or improve muscle mass recovery in the
soleus of these animals (data not shown).
In contrast to hindlimb suspension, resveratrol treatment
enhanced the recovery of plantaris muscle mass during
reloading after the period of disuse. This appeared to be the
result, at least in part, of a resveratrol mediated improvement in
type IIA and type IIB fiber size as compared to the vehicle
treatment. It is interesting to note that type I fibers were unable
to regain the hindlimb suspension-induced lost muscle fiber
size even after 14 days of reloading in either resveratrol or
vehicle treated old animals (data not shown).
It was not surprising that resveratrol improved muscle fiber
size, given that similar results have been observed in several
recent studies [17,18]. These beneficial effects observed in our
current study are likely due in part to the ability of resveratrol to
attenuate muscle protein degradation during conditions which
normally would induce atrophy [17] or stressful conditions that
are resistant to hypertrophy. Although not significant,
resveratrol tended to enhance the proliferation of muscle
progenitor stem cells (e.g., satellite cells) during the recovery
period, and once the cells had differentiated, they would be
expected to provide a greater population of nuclei to participate
in muscle re-growth. Thus, we cannot fully rule out the
possibility that resveratrol increased the growth response
during recovery following our suspension-induced atrophy
protocol.
The rightward shift in the force-frequency curve especially
during recovery after hindlimb suspension is suggestive of a
faster muscle phenotype, which is consistent with our
observations of a type I to type II fiber composition change in
the plantaris muscles. While the proportion of fibers that
expressed type I myosin heavy chain decreased in the
plantaris from both the resveratrol and vehicle treated animals
following suspension, there was a significant increase in the
Figure 10.  Apoptotic signaling proteins in plantaris muscles.  Plantaris muscle samples were homogenized and total muscle
lysates were separated on a 4-12% gradient polyacrylamide gel by routine SDS-PAGE. The proteins were electroblotted to
nitrocellulose membranes and the signals were developed by chemiluminescence. A. Representative western blots of apoptotic
proteins. Bax, Bcl-xL, Bcl-2, cleaved caspase 3 (CC-3), cleaved caspase 9 (CC-9) and GAPDH. The digital images were quantified
as optical density x band area using ImageJ software and normalized to GAPDH, which was used as the loading control for each
lane. The data are expressed as the protein signal to the GAPDH signal and are reported as mean ± SEM in arbitrary units. The
western blots were run a minimum of three times for each protein, and the data were averaged for each animal’s data point. These
data include: Bax (B) Bcl-2 (C), Bcl-xL (D), cleaved caspase 3 (E), and cleaved caspase 9 (F). * P<0.05 vs. cage control; † P<0.05
vehicle vs. resveratrol.
doi: 10.1371/journal.pone.0083518.g010
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percentage of type IIB fibers during this period. The percent of
type IIA and IIB fibers in the plantaris was not different between
resveratrol and vehicle treated animals in the recovery period.
This suggests that resveratrol has a minor or no effect on
myosin expression under the hindlimb suspension and
reloading conditions of this study, yet, it did improve the
amount of protein in plantaris in a fiber type specific fashion in
the reloaded muscles. This was shown by larger type IIA and
IIB fibers in resveratrol treated animals of the recovery group.
These results were slightly different than that reported in a
study by Momken and colleagues [18]. Under similar
experimental conditions as our present study, they observed
that resveratrol supplementation attenuated the decrease in the
proportion of type I fibers following suspension [18]. They
attributed this finding to the ability of resveratrol, acting
primarily through Sirt1, to increase the expression of PGC1α,
which has been shown to promote the maintenance of slow-
twitch fiber’s oxidative characteristics [34]. However, in our
study, PGC1α protein levels increased but Sirt1 activity and
protein abundance were not significantly improved in the
resveratrol treated animals that were in the recovery group.
Nevertheless, we do not know if the increase in PGC1α
occurred in both type I and type II fibers of the fast glycolytic
plantaris muscle that was examined in our current study,
whereas the slow and more oxidative soleus muscles soleus
was examined by Momken et al. [18]. The effects of resveratrol
Figure 11.  Immunocytochemical evidence for apoptotic nuclei in reloaded muscles.  DNA fragmentation was assessed with
TUNEL staining (green) as an indication of nuclei committed to apoptosis in the plantaris muscles from animals. The basal lamina of
the muscle fibers was incubated in an anti-lamina antibody (red) to identify nuclei adjacent to or inside the basal lamina of the fibers.
Representative tissue cross sections are shown for animals in the hindlimb suspension (A) and recovery (B) groups. C.
Quantification of the TUNEL positive nuclei that were located at or below the basal lamina of the muscle fibers in the recovery or
cage control animals. *P<0.05 vs. cage control.
doi: 10.1371/journal.pone.0083518.g011
Resevartrol and Muscle Recovery Following Disuse
PLOS ONE | www.plosone.org 16 December 2013 | Volume 8 | Issue 12 | e83518
might be muscle specific because type I fibers in the plantaris
of resveratrol and vehicle treated animals had similar
reductions in cross sectional area after hindlimb suspension or
recovery. Our data suggest that type II fibers may be sensitive
to resveratrol-regulated recovery, whereas type I fibers are
resistant to re-growth after a period of disuse at least at the
doses of resveratrol and the ages of animals that were
examined in this study.
Resveratrol reduces apoptotic signaling during
reloading
Resveratrol has been shown to provide beneficial effects on
apoptosis in multiple different tissues [19,35–37]. Therefore, we
examined if resveratrol altered the apoptotic signaling in the
plantaris muscles of old rats during recovery from hindlimb
suspension. This is important because apoptosis is elevated in
skeletal muscle with aging and disuse [38–41]. As expected,
hindlimb suspension increased pro-apoptotic signaling as
evidenced by elevations in Bax, cleaved caspase 3 and
cleaved caspase 9 in the plantaris muscles after hindlimb
suspension. During the recovery period, resveratrol
suppressed each of these pro-apoptotic proteins as compared
to their protein abundance in vehicle treated animals. While
resveratrol returned Bax to control levels in the plantaris
muscles of the recovery animals, cleaved caspase 3 and
cleaved caspase 9 protein abundance fell below control levels
during the recovery period in the plantaris muscles of
resveratrol treated animals. This resveratrol-enhanced
reduction in pro-apoptotic signaling was accompanied by an
improvement in Bcl-2 protein abundance during recovery,
although Bcl-xL was not different in vehicle and resveratrol
treated animals of the recovery group. While TUNEL index
values were slightly lower in the resveratrol treated animals of
the recovery group as compared to the vehicle treated animals,
this did not reach statistical significance. Nevertheless, this
small change may have been physiologically relevant because
we do not know how many nuclei need to be spared from dying
in order to improve muscle hypertrophy. Coupled with the
increases in Bcl-2 and the reductions in Bax, cleaved caspase
3 and cleaved caspase 9, it is possible that these changes to a
muscle environment that is less favorable for apoptosis, could
have prevented the loss of some nuclei, which may have
contributed to an improvement in muscle recovery, especially
in type II fibers, after disuse in the animals of this study. It
should be noted that other compounds have also been shown
to reduce apoptotic signaling in this model of unloading and
loading, including HMB [13] and therefore, apoptotic signaling
might be a good target to reduce muscle wasting and/or
improve muscle recovery after disuse in aging.
Muscle function
The fatigue index revealed a decrease in the ability of the
plantaris to withstand repeated contractions in both of the
groups subjected to suspension or after reloading. It was
unexpected that after reloading following hindlimb suspension,
the resveratrol treated animals would have a reduced fatigue
index as compared to the control group while the vehicle
treated animals had a similar fatigue index as the control
animals. The lower fatigue index in the resveratrol treated
animals occurred, despite having greater PGC1α levels which
would have been expected to stimulate mitochondrial
biogenesis. Nevertheless, the larger type IIA and type IIB fibers
in the resveratrol treated muscles of the recovery group would
not be expected to confer improved fatigue resistance, so it is
possible that the larger mitochondrial poor fibers in the
plantaris might have diluted the anticipated improvement in
fatigue resistance by resveratrol. However, the observation that
resveratrol treatment does not improve upon the fatigue index
is not without precedent. In other studies involving resveratrol
supplementation [26,42], no improvements were observed in
muscle fatigability. Nonetheless, it must also be noted that in
one study in which young, dystrophic mdx mice were
supplemented with resveratrol, there was a significant
improvement of the fatigue index [43]. It is possible that the
effect of resveratrol on muscle fatigue might be specific to the
experimental models, dose of resveratrol, and intervention that
was employed. Therefore, further research in the effects of
resveratrol on muscle fatigue is needed to reconcile these
discrepancies.
Study limitations
The potential limitation of this study is that the dose of
resveratrol used, while higher than another study which
showed reduced oxidative stress [44] was simply not enough to
elicit the full benefits of its regenerative capabilities on all fiber
types. It is possible that reduced absorption in the
gastrointestinal track of the old rats, or increased rates of
metabolism of resveratrol as a first past through the liver, may
have reduced the effectiveness of the compound during the
high stress conditions of unloading and reloading. Furthermore
we do not know why the plasma levels of resveratrol decreased
in the recovery animals as compared to the hindlimb
suspension animals. If this also occurred during long-term
resveratrol use (perhaps by elevating the liver associated
metabolism of resveratrol), this might explain why resveratrol,
which reduced muscle levels of oxidative stress, was unable to
attenuate muscle losses due to aging, when it was given to
mice over a period of 10 months [26]. While, the resveratrol
administered by gavage in the current study, was the same in
both groups, we cannot rule out the possibility that the dietary
intake of resveratrol in the food differed under hindlimb
suspension and recovery conditions. Nevertheless, our
observations in other studies using the suspension and
reloading model, have not detected a reduction in food intake
in the recovery vs. the unloading period [30]. Thus, we
speculate that the most likely explanation is that resveratrol
metabolism might have differed (increased) during the recovery
period as compared to the hindlimb suspension condition.
Nevertheless, the evidence from this study provides a basis for
conducting further research to optimize the dose or timing of
resveratrol supplementation in aging and perhaps examine
resveratrol metabolites in more detail during unloading and
reloading. In addition, translational research is needed to
evaluate resveratrol’s potential as a countermeasure to reduce
the decline of muscle function or mass in the elderly following
periods of forced disuse.
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Summary
The findings from our present study provide evidence for the
modest but potentially important benefits of resveratrol
supplementation in improving skeletal muscle regeneration
following a period of disuse with a subsequent recovery in
aging. Although resveratrol did not prevent either body or
muscle weight loss following hindlimb suspension, it was able
to induce favorable changes to type IIA and type IIB muscle
fiber CSA and reduce apoptotic signaling in muscles of old
animals. This is particularly relevant in the elderly population
which experience preferential atrophy of type II fibers in
sarcopenia.
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